ARS Pharmaceuticals, Inc. (SPRY)
9.07
0.00 (0.00%)
USD |
NASDAQ |
Jun 01, 09:47
ARS Pharmaceuticals EPS Diluted (Quarterly) : -0.6105 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 0.2446 |
| Heron Therapeutics, Inc. | -0.0428 |
| ACADIA Pharmaceuticals, Inc. | 0.0211 |
| Alnylam Pharmaceuticals, Inc. | 1.508 |
| Anika Therapeutics, Inc. | -0.3737 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -60.62M |
| Revenue (Quarterly) | 22.68M |
| Total Expenses (Quarterly) | 83.30M |
| Enterprise Value | 796.83M |
| Gross Profit Margin (Quarterly) | 72.29% |
| Profit Margin (Quarterly) | -267.3% |
| Earnings Yield | -22.07% |
| Normalized Earnings Yield | -22.07 |